The BRIDGE Project
BRIDGE
1 other identifier
interventional
60
1 country
1
Brief Summary
The BRIDGE project: A feasibility randomised controlled trial of brief, intensive assessment and integrated formulation for young people (age 14-24) early in the course of borderline personality disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2021
CompletedFirst Posted
Study publicly available on registry
August 26, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedApril 26, 2024
April 1, 2024
2.7 years
July 9, 2021
April 24, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Recruitment & Retention rates
The number of participants recruited for randomisation and the number retained to follow-up (12 \& 24wks post randomisation).
Continuous over 3 year study period
Secondary Outcomes (2)
Acceptability of trial processes and interventions
Continuous over 3 year study period
Process Evaluation
Continuous over 3 year study period
Other Outcomes (14)
Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II) PQ-BPD
Screening; Pre-randomisation
Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II) DSM-V
Screening/Pre-randomisation
KIDSCREEN-10 Index
Screening/Pre-randomisation
- +11 more other outcomes
Study Arms (2)
BRIDGE Intervention (+Service as Usual)
EXPERIMENTALBrief, intensive assessment and integrated formulation (BRIDGE) intervention is guided by the evidence base of Cognitive Analytic Therapy (CAT) with young people (aged 14-25) with features of BPD using an early intervention model and in collaboration with an established Glasgow programme, Intensive Support and Monitoring Service (ISMS). ISMS focuses on reaching a shared formulation with the young person and the multi-agency system that supports them. BRIDGE is delivered over 3-6 months and includes :- an intensive assessment, including BPD symptoms, copresenting difficulties, neurodevelopmental profile, life events history and psychosocial functioning; up to 16 sessions of Cognitive Analytic Therapy (CAT) and the development of a shared formulation with a multi-agency group. Further development of this formulation with the young person, using CAT principles (Reformulation, Recognition and Revision) and, where clinically applicable, their family and service-providers.
Service as Usual
ACTIVE COMPARATORServices as Usual (SAU) For participants randomised to SAU, a routine letter of their participation will be shared with their service provider(s), including their GP. SAU, is likely to range from social services, mental-health services, forensic services to no services in some cases. Pathways to care and service involvement will be mapped and described for each participant. Treatment fidelity to SAU will therefore not be assessed, but the nature and intensity of SAU in different contexts will be described in detail through the qualitative process evaluation.
Interventions
Intensive clinical assessment; \>16 sessions of Cognitive Analytic Therapy (CAT); Development of a shared formulation
Likely to range from social services, mental-health services, forensic services to no intervention
Eligibility Criteria
You may qualify if:
- Cut off score of 11 out of 15 on the self-reported SCID-II BPD questionnaire AND subthreshold (3 or 4 out of 9 domains) or threshold (5 and above out of 9 domains) criteria on the SCID-II DSM-V (BPD Module)
- Age 14-25
You may not qualify if:
- Currently receiving psychological/counselling /psychotherapeutic treatment for BPD
- Has received psychological/counselling/psychotherapeutic intervention for over 8 sessions in the last 3 months
- Severe or profound intellectual disability, that would preclude full engagement in talking therapy
- Receiving Intensive psychiatric treatment at the time of study entry, for conditions such as acute psychosis or severe eating disorder
- Non-English speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Greater Glasgow and Clydelead
- University of Glasgowcollaborator
Study Sites (1)
NHS Greater Glasgow and Clyde Clinical Research and Development Central Office
Paisley, PA2 7DE, United Kingdom
Related Publications (1)
Gajwani R, Sim F, McAllister K, Smith H, McIntosh E, Moran P, Ougrin D, Smith M, Gumley AI, Chanen AM, Minnis H. The BRIDGE project: a feasibility randomised controlled trial of brief, intensive assessment and integrated formulation for young people (age 14-24) with features of borderline personality disorder (Protocol). Front Psychiatry. 2024 Sep 24;15:1389578. doi: 10.3389/fpsyt.2024.1389578. eCollection 2024.
PMID: 39381608DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ruchika Gajwani, Dr
University of Glasgow
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Randomized
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2021
First Posted
August 26, 2021
Study Start
September 1, 2021
Primary Completion
April 30, 2024
Study Completion
September 30, 2024
Last Updated
April 26, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
The PI will manage access rights to the data set. We anticipate that anonymised trial data may be shared with other researchers to contribute to the emerging BPD evidence base.